Mark Shackleton

MBBS, FRACP, PhD, Director of Medical Oncology, Victorian Melanoma Service, Alfred Health Melbourne, Vic; Laboratory Head, Central Clinical School, Monash University, Melbourne, Vic; Director of Medical Oncology, Department of Medical Oncology, Alfred Health, Vic

Reduced melanoma referrals during COVID-19 lockdown

As the COVID-19 pandemic has reduced face-to-face medical consultations, reduced diagnoses of thin melanomas and delayed presentations of thick melanomas were anticipated.

Immune-related adverse events secondary to immunotherapy in oncology: A guide for general practice

This study aims to provide a general overview of immunotherapy and irAEs, highlighting common clinical scenarios and general principles of management.